Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

被引:0
|
作者
Basli, Abdelkader [1 ,2 ]
Bounaas, Jihane [1 ]
机构
[1] Univ Skikda, Fac Sci, Lab Interact Res Biodivers Ecosyst & Biotech, Skikda, Algeria
[2] Univ August 20 1955, 1955 BP 26,Rd El Hadaiek, Skikda 21000, Algeria
关键词
Alzheimer's disease; amyloid beta; tau protein; novel therapies; AMYLOID-BETA-PEPTIDE; APOLIPOPROTEIN-E; TAU-PROTEIN; NITRIC-OXIDE; POSTTRANSLATIONAL MODIFICATIONS; GAMMA-SECRETASE; PHOSPHORYLATION; PEROXYNITRITE; AGGREGATION; INHIBITION;
D O I
10.1177/02601060221137104
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Alzheimer's disease (AD) is characterized by the presence of two types of protein deposits in the brain, amyloid plaques and neurofibrillary tangles. The first one are dense deposits of beta amyloid protein, the second one are dense deposits of the protein tau. These proteins are present in all of our brains, but in AD they act unusually, leading to neuronal degeneration. This review will provide an overview of the AD, including the role of amyloid beta and tau, and mechanisms that lead to the formation of plaques and tangles. The review will also cover the existing researches that have focused on the inhibition of amyloid beta formation, cholinesterase, tau hyperphosphorylation, the pathogenic mechanisms of apoE4, and GSK-3 as a solution that could be used to slow or prevent the disease.
引用
收藏
页码:403 / 413
页数:11
相关论文
共 50 条
  • [41] Glycogen synthase kinase 3β and Alzheimer's disease:: pathophysiological and therapeutic significance
    Balaraman, Y.
    Limaye, A. R.
    Levey, A. I.
    Srinivasan, S.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (11) : 1226 - 1235
  • [42] Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance
    Y. Balaraman
    A. R. Limaye
    A. I. Levey
    S. Srinivasan
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1226 - 1235
  • [43] Calcium Signalling in Alzheimer's Disease: From Pathophysiological Regulation to Therapeutic Approaches
    Chami, Mounia
    CELLS, 2021, 10 (01)
  • [44] Therapeutic Effects of Natural Drugs on Alzheimer's Disease
    Ma, Yuan
    Yang, Man-wen
    Li, Xin-wei
    Yue, Jian-wei
    Chen, Jun-zong
    Yang, Mei-wen
    Huang, Xuan
    Zhu, Lian-lian
    Hong, Fen-fang
    Yang, Shu-long
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [45] Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals
    Sawikr, Yousef
    Yarla, Nagendra Sastry
    Peluso, Ilaria
    Kamal, Mohammad Amjad
    Aliev, Gjumrakch
    Bishayee, Anupam
    STRESS AND INFLAMMATION IN DISORDERS, 2017, 108 : 33 - 57
  • [46] Gonadotropins: potential targets for preventive and therapeutic interventions in Alzheimer's disease
    Barron, Anna M.
    Verdile, Giuseppe
    Martins, Ralph N.
    FUTURE NEUROLOGY, 2006, 1 (02) : 189 - 202
  • [47] PREVENTIVE AND THERAPEUTIC STRATEGIES IN CELIAC DISEASE
    Branski, D.
    ACTA PAEDIATRICA, 2010, 99 : 14 - 14
  • [48] The glutamatergic system and neurodegeneration in dementia: Preventive strategies in Alzheimer's disease
    Cacabelos, R
    Takeda, M
    Winblad, B
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1999, 14 (01) : 3 - 47
  • [49] Therapeutic mechanism of Acorus tatarinowii on Alzheimer′s disease
    YAN Meng
    HU Beibei
    ZHANG Danshen
    JING Yongshuai
    中国药理学与毒理学杂志, 2023, 37 (07) : 500 - 500
  • [50] Aneuploidy and adult neurogenesis in Alzheimer's disease: therapeutic strategies
    Taupin, Philippe
    DRUG DISCOVERY TODAY, 2010, 15 (23-24) : 983 - 984